{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:32:46Z","timestamp":1791340366131,"version":"4.3.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,17]],"date-time":"2024-11-17T00:00:00Z","timestamp":1731801600000},"content-version":"am","delay-in-days":352,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.kint.2023.09.010","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T15:32:38Z","timestamp":1695742358000},"page":"1206-1218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["The spectrum of glomerular and vascular kidney pathology associated with myeloproliferative neoplasms"],"prefix":"10.1016","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6084-5836","authenticated-orcid":false,"given":"Thibaut","family":"d\u2019Izarny-Gargas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1880-7596","authenticated-orcid":false,"given":"Pierre","family":"Isnard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idris","family":"Boudhabhay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Buob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6015-3979","authenticated-orcid":false,"given":"Anissa","family":"Moktefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8350-8074","authenticated-orcid":false,"given":"Charel","family":"Linster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Hummel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3656-8557","authenticated-orcid":false,"given":"Emmanuel","family":"Esteve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5343-2550","authenticated-orcid":false,"given":"Vincent","family":"Audard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1500-3736","authenticated-orcid":false,"given":"H\u00e9l\u00e8ne","family":"Lazareth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Maroun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2903-3303","authenticated-orcid":false,"given":"Alexandre","family":"Hertig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Gosset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Jouzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Permal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Domenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6021-4057","authenticated-orcid":false,"given":"Olivier","family":"Kosmider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Rabant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3075-7739","authenticated-orcid":false,"given":"Alexandre","family":"Karras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3051-2141","authenticated-orcid":false,"given":"Jean-Paul","family":"Duong Van Huyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2023.09.010_bib1","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1182\/blood-2017-06-782037","article-title":"Myeloproliferative neoplasms: from origins to outcomes","volume":"130","author":"Nangalia","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.kint.2023.09.010_bib2","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.kint.2023.09.010_bib3","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1182\/blood.2020008043","article-title":"Clinical insights into the origins of thrombosis in myeloproliferative neoplasms","volume":"137","author":"Moliterno","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.kint.2023.09.010_bib4","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/s00277-019-03690-2","article-title":"Assessment of chronic renal injury in patients with chronic myeloid leukemia in the chronic phase receiving tyrosine kinase inhibitors","volume":"98","author":"Ren","year":"2019","journal-title":"Ann Hematol"},{"key":"10.1016\/j.kint.2023.09.010_bib5","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s12185-019-02596-z","article-title":"Renal dysfunction and anemia associated with long-term imatinib treatment in patients with chronic myelogenous leukemia","volume":"109","author":"Sakurai","year":"2019","journal-title":"Int J Hematol"},{"key":"10.1016\/j.kint.2023.09.010_bib6","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3904\/kjim.2016.263","article-title":"Chronic kidney disease in the BCR-ABL1-negative myeloproliferative neoplasm: a single-center retrospective study","volume":"33","author":"Baek","year":"2018","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.kint.2023.09.010_bib7","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.leukres.2014.01.014","article-title":"Chronic kidney disease in patients with the Philadelphia-negative chronic myeloproliferative neoplasms","volume":"38","author":"Christensen","year":"2014","journal-title":"Leuk Res"},{"key":"10.1016\/j.kint.2023.09.010_bib8","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1007\/s00277-020-04239-4","article-title":"Reduced renal function strongly affects survival and thrombosis in patients with myelofibrosis","volume":"99","author":"Lucijanic","year":"2020","journal-title":"Ann Hematol"},{"key":"10.1016\/j.kint.2023.09.010_bib9","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0272-6386(99)70047-8","article-title":"Focal segmental glomerulosclerosis and mesangial sclerosis associated with myeloproliferative disorders","volume":"34","author":"Au","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2023.09.010_bib10","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/ki.2011.147","article-title":"Myeloproliferative neoplasms cause glomerulopathy","volume":"80","author":"Said","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2023.09.010_bib11","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/his.14282","article-title":"Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome\/myeloproliferative neoplasms","volume":"78","author":"B\u00fcttner-Herold","year":"2021","journal-title":"Histopathology"},{"key":"10.1016\/j.kint.2023.09.010_bib12","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00428-021-03129-y","article-title":"Renal post-mortem findings in myeloproliferative and myelodysplastic\/myeloproliferative neoplasms","volume":"479","author":"Person","year":"2021","journal-title":"Virchows Arch"},{"key":"10.1016\/j.kint.2023.09.010_bib13","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ekir.2020.12.005","article-title":"Kidney involvement in patients with chronic myelomonocytic leukemia or BCR-ABL\u2013negative myeloproliferative neoplasms","volume":"6","author":"Belliere","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2023.09.010_bib14","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/10428194.2018.1474525","article-title":"Renal complications of primary myelofibrosis","volume":"60","author":"Strati","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.kint.2023.09.010_bib15","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/modpathol.2015.117","article-title":"Renal extramedullary hematopoiesis: interstitial and glomerular pathology","volume":"28","author":"Alexander","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.kint.2023.09.010_bib16","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1182\/bloodadvances.2018025874","article-title":"Analysis of cardiovascular and arteriothrombotic adverse events in chronic-phase CML patients after frontline TKIs","volume":"3","author":"Jain","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.kint.2023.09.010_bib17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.leukres.2017.05.008","article-title":"Risk factors and mechanisms contributing to TKI-induced vascular events in patients with CML","volume":"59","author":"Valent","year":"2017","journal-title":"Leuk Res"},{"key":"10.1016\/j.kint.2023.09.010_bib18","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1007\/s00277-017-3099-2","article-title":"The underappreciated risk of thrombosis and bleeding in patients with myelofibrosis: a review","volume":"96","author":"KC","year":"2017","journal-title":"Ann Hematol"},{"key":"10.1016\/j.kint.2023.09.010_bib19","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1182\/blood.2020008109","article-title":"The pathobiology of thrombosis, microvascular disease, and hemorrhage in the myeloproliferative neoplasms","volume":"137","author":"Hasselbalch","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.kint.2023.09.010_bib20","first-page":"1606","article-title":"Clonal hematopoiesis and non-hematologic disorders","volume":"136","author":"Jaiswal","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.kint.2023.09.010_bib21","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.3390\/cancers12082100","article-title":"Clonal hematopoiesis and mutations of myeloproliferative neoplasms","volume":"12","author":"Kj\u00e6r","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.kint.2023.09.010_bib22","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/CIRCRESAHA.117.312115","article-title":"Somatic mutations and clonal hematopoiesis: unexpected potential new drivers of age-related cardiovascular disease","volume":"122","author":"Fuster","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.kint.2023.09.010_bib23","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A\u00a0new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.kint.2023.09.010_bib24","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1097\/TP.0000000000002366","article-title":"2018 reference guide to the Banff Classification of Renal Allograft Pathology","volume":"102","author":"Roufosse","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2023.09.010_bib25","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.kint.2017.01.002","article-title":"A\u00a0proposal for standardized grading of chronic changes in native kidney biopsy specimens","volume":"91","author":"Sethi","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2023.09.010_bib26","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1046\/j.1523-1755.2003.00886.x","article-title":"Risk factors for renal glomerular and vascular changes in an autopsy-based population survey: the Hisayama study","volume":"63","author":"Kubo","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2023.09.010_bib27","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1161\/01.ATV.17.4.760","article-title":"Cardiovascular risk factors and hyalinization of renal arterioles at autopsy: the Honolulu Heart Program","volume":"17","author":"Burchfiel","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.kint.2023.09.010_bib28","first-page":"561","article-title":"The association between age and nephrosclerosis on renal biopsy among healthy adults","volume":"152","author":"Rule","year":"2010"},{"key":"10.1016\/j.kint.2023.09.010_bib29","series-title":"R: a language and environment for statistical computing","year":"2022"},{"key":"10.1016\/j.kint.2023.09.010_bib30","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"J\u00a0Open Source Softw"},{"key":"10.1016\/j.kint.2023.09.010_bib31","series-title":"Tableone: create \u201cTable 1\u201d to describe baseline characteristics with or without propensity score weights","author":"Yoshida","year":"2022"},{"key":"10.1016\/j.kint.2023.09.010_bib32","series-title":"Knitr: a general-purpose package for dynamic report generation in R; 2022","author":"Xie","year":"2022"},{"key":"10.1016\/j.kint.2023.09.010_bib33","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1681\/ASN.2017040421","article-title":"Structural and functional changes in human kidneys with healthy aging","volume":"28","author":"Hommos","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.09.010_bib34","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/j.ekir.2022.05.036","article-title":"Age-related changes in renal arterio-arteriolosclerosis in kidney disease: renal biopsy-based study","volume":"7","author":"Oshiro","year":"2022","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2023.09.010_bib35","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1182\/blood-2016-05-715987","article-title":"Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature","volume":"128","author":"Kavanagh","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.kint.2023.09.010_bib36","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/ndt\/16.4.846","article-title":"Renal thrombotic microangiopathy induced by interferon-\u03b1","volume":"16","author":"Badid","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2023.09.010_bib37","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1172\/JCI124566","article-title":"Erythrocyte-derived microvesicles induce arterial spasms in JAK2V617F myeloproliferative neoplasm","volume":"130","author":"Poisson","year":"2020","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2023.09.010_bib38","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1182\/blood-2008-11-191544","article-title":"The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome","volume":"113","author":"Sozer","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.kint.2023.09.010_bib39","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1073\/pnas.1312148111","article-title":"JAK2V617F-positive endothelial cells contribute to clotting abnormalities in myeloproliferative neoplasms","volume":"111","author":"Etheridge","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2023.09.010_bib40","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1055\/s-0038-1667015","article-title":"Endothelial cells harbouring the JAK2V617F mutation display pro-adherent and pro-thrombotic features","volume":"118","author":"Guadall","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.kint.2023.09.010_bib41","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1002\/cam4.2886","article-title":"Thrombosis among 1537 patients with JAK2V617F-mutated myeloproliferative neoplasms: risk factors and development of a predictive model","volume":"9","author":"Zhang","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.kint.2023.09.010_bib42","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3343\/alm.2012.32.6.385","article-title":"Correlations between Janus Kinase 2 V617F allele burdens and clinicohematologic parameters in myeloproliferative neoplasms","volume":"32","author":"Ha","year":"2012","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.kint.2023.09.010_bib43","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.3390\/cancers13164086","article-title":"Kidney dysfunction is associated with thrombosis and disease severity in myeloproliferative neoplasms: implications from the German Study Group for MPN Bioregistry","volume":"13","author":"Gecht","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.kint.2023.09.010_bib44","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12185-020-02898-7","article-title":"Chronic kidney disease could be a risk factor for thrombosis in essential thrombocythemia and polycythemia vera","volume":"112","author":"Kre\u010dak","year":"2020","journal-title":"Int J Hematol"},{"key":"10.1016\/j.kint.2023.09.010_bib45","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/sj.ki.5001551","article-title":"Renal vascular sclerosis is associated with inherited thrombophilias","volume":"70","author":"Goforth","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2023.09.010_bib46","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2023.09.010_bib47","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/STROKEAHA.121.037388","article-title":"Clonal hematopoiesis is associated with higher risk of stroke","volume":"53","author":"Bhattacharya","year":"2022","journal-title":"Stroke"},{"key":"10.1016\/j.kint.2023.09.010_bib48","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1126\/science.aag1381","article-title":"Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice","volume":"355","author":"Fuster","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.kint.2023.09.010_bib49","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jacc.2017.12.037","article-title":"Tet2-mediated clonal hematopoiesis accelerates heart failure through a mechanism involving the IL-1\u03b2\/NLRP3 inflammasome","volume":"71","author":"Sano","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.kint.2023.09.010_bib50","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.135204","article-title":"Tet2-mediated clonal hematopoiesis in nonconditioned mice accelerates age-associated cardiac dysfunction","volume":"5","author":"Wang","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.kint.2023.09.010_bib51","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1681\/ASN.2021060774","article-title":"Association of clonal hematopoiesis of indeterminate potential with worse kidney function and anemia in two cohorts of patients with advanced chronic kidney disease","volume":"33","author":"Vlasschaert","year":"2022","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.09.010_bib52","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41375-021-01382-3","article-title":"Clonal myelopoiesis promotes adverse outcomes in chronic kidney disease","volume":"36","author":"Dawoud","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.kint.2023.09.010_bib53","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1053\/j.ajkd.2022.08.014","article-title":"Clonal hematopoiesis of indeterminate potential and kidney function decline in the general population","volume":"81","author":"Kestenbaum","year":"2023","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2023.09.010_bib54","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/ejh.13845","article-title":"Clonal haematopoiesis of indeterminate potential and impaired kidney function\u2014a Danish general population study with 11 years follow-up","volume":"109","author":"Larsen","year":"2022","journal-title":"Eur J Haematol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253823006725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253823006725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T05:34:16Z","timestamp":1715146456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253823006725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0085253823006725"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2023.09.010","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The spectrum of glomerular and vascular kidney pathology associated with myeloproliferative neoplasms","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2023.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}